文献速递心力衰竭与心肌病血脂与心血管预防

β淀粉样蛋白病理影响阿尔茨海默病患者的心脏:关注心脏

Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer's Disease: Mind the Heart.
PubMed 文献 · J Am Coll Cardiol · 2016-01-01

该回顾性横断面研究比较阿尔茨海默病患者与年龄匹配对照的心肌功能,发现患者存在预期的舒张功能障碍,且心脏中Aβ40和Aβ42表达增加。作者首次报告AD患者存在心肌功能受损和心肌内Aβ沉积,提出AD可能为系统性疾病或转移性疾病导致心脏及多器官衰竭的新生物学框架。

要点

  • 阿尔茨海默病患者超声心动图提示存在预期的舒张功能障碍。
  • 心脏中Aβ40和Aβ42表达在阿尔茨海默病患者中增加。
  • 首次报告AD患者心肌功能受损和心肌内Aβ沉积。

核心结论

  • 首次报告阿尔茨海默病患者存在心肌功能受损和心肌内Aβ沉积。
  • 研究描绘了AD可能被视为系统性疾病或转移性疾病导致心脏及多器官衰竭的新生物学框架。
  • 作者认为这一被忽视的问题需要新的诊断方法和治疗。

研究设计与样本

  • 回顾性横断面研究,纳入阿尔茨海默病患者队列及年龄匹配对照。
  • 采用影像学和蛋白质组学方法鉴定和定量AD心脏和脑标本中的Aβ沉积并与对照比较。
  • 在分离的成人心肌细胞上测量细胞缩短和钙瞬变。

主要发现

  • 超声心动图测量提示阿尔茨海默病患者存在预期的舒张功能障碍。
  • 与脑内类似,心脏中存在Aβ40和Aβ42,且其在AD中表达增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Individually, heart failure (HF) and Alzheimer's disease (AD) are severe threats to population health, and their potential coexistence is an alarming prospect. In addition to sharing analogous epidemiological and genetic profiles, biochemical characteristics, and common triggers, the authors recently recognized common molecular and pathological features between the 2 conditions. Whereas cognitive impairment has been linked to HF through perfusion defects, angiopathy, and inflammation, whether patients with AD present with myocardial dysfunction, and if the 2 conditions bear a common pathogenesis as neglected siblings are unknown. OBJECTIVES: Here, the authors investigated whether amyloid beta (Aβ) protein aggregates are present in the hearts of patients with a primary diagnosis of AD, affecting myocardial function. METHODS: The authors examined myocardial function in a retrospective cross-sectional study from a cohort of AD patients and age-matched controls. Imaging and proteomics approaches were used to identify and quantify Aβ deposits in AD heart and brain specimens compared with controls. Cell shortening and calcium transients were measured on isolated adult cardiomyocytes. RESULTS: Echocardiographic measurements of myocardial function suggest that patients with AD present with an anticipated diastolic dysfunction. As in the brain, Aβ40 and Aβ42 are present in the heart, and their expression is increased in AD. CONCLUSIONS: Here, the authors provide the first report of the presence of compromised myocardial function and intramyocardial deposits of Aβ in AD patients. The findings depict a novel biological framework in which AD may be viewed either as a systemic disease or as a metastatic disorder leading to heart, and possibly multiorgan failure. AD and HF are both debilitating and life-threatening conditions, affecting enormous patient populations. Our findings underline a previously dismissed problem of a magnitude that will require new diagnostic approaches and treatments for brain and heart disease, and their combination.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Troncone L, Luciani M, Coggins M, et al. Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer's Disease: Mind the Heart. J Am Coll Cardiol. 2016. PMID: 27908343. doi:10.1016/j.jacc.2016.08.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。